You can buy or sell LYRA and other stocks, options, and ETFs commission-free!
Lyra Therapeutics, Inc. Common Stock, also called Lyra Therapeutics, is a clinical-stage therapeutics company. It develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases. The firms proprietary XTreo deliver medicines. The company was founded by Carmichael S. Roberts, George M. Whitesides, and Robert S. Langer and is headquartered in Watertown, MA. The listed name for LYRA is Lyra Therapeutics, Inc. Common Stock.
52 Week High
52 Week Low
— per share
Expected Mar 11, After Hours